The PedCRIN funded WE Study (Walking Easier with cerebral palsy) is a double blind placebo controlled randomized trial in children between 4-17 years. This trial will enrol 96 children in three European countries: Norway, France and Poland. The Polish site had first patient included this week
Launched in January 2017, PedCRIN is a four-year project funded by the European Union’s Horizon 2020 programme (GA731046). PedCRIN aims to develop the capacity of ECRIN (European Clinical Research Infrastructure) for the management of multi-national paediatric non-commercial clinical trials. PedCRIN was founded in response to the widely acknowledged difficulties in conducting investigator-led trials of investigational medicinal products in children in a multinational setting. PedCRIN seeks to effectively bridge paediatricians and other partners across and beyond Europe to combine resources and expertise to conduct, manage and execute robust studies, whilst minimising risk and protecting the child participants.